Part 1: Mucormycosis: prevalence, risk factors, clinical features, and diagnosis

By sjmartinez • June 30, 2023

Lynch JP 3rd, Fishbein MC, Abtin F, Zhanel GG. Part 1: Mucormycosis: prevalence, risk factors, clinical features, and diagnosis. Expert Rev Anti Infect Ther. 2023 Jul-Dec;21(7):723-736. doi: 10.1080/14787210.2023.2220964. Epub 2023 Jun 7. PMID: 37262298.

Tags: Diagnosis, invasive fungal infections, mold, Mucorales, mucormycosis, Publications, Pulmonary, Critical Care & Sleep Medicine, Rhizopus, Zygomycosis, Zyzomyces

Serine protease inhibitor, SerpinA3n regulates cardiac remodeling after myocardial infarction

Sun Q, Chen W, Wu R, Tao B, Wang P, Sun B, Alvarez JF, Ma F, Galindo DC, Maroney SP, Saviola AJ, Hansen KC, Li[...]

Cost effectiveness of hepatitis C direct acting agents

Shetty A, Lee M, Valenzuela J, Saab S. Cost effectiveness of hepatitis C direct acting agents. Expert Rev Pharmacoecon Outcomes Res. 2024 Apr 26. doi:[...]

[68Ga]Ga-FAPI-46 False-Positive Uptake After Chemotherapy in Nonseminomatous Germ Cell Tumor Metastatic Lesions

Ludwig V, Maliha PG, Shen J, Tonnelet D, Raman S, Litwin MS, Calais J. [68Ga]Ga-FAPI-46 False-Positive Uptake After Chemotherapy in Nonseminomatous Germ Cell Tumor Metastatic[...]